G. Barnett

发表

Independent validation of genes and polymorphisms reported to be associated with radiation toxicity: a prospective analysis study.

M. Sydes, D. Dearnaley, A. Dunning, 2012, The Lancet. Oncology.

A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity.

M. Sydes, D. Dearnaley, P. Pharoah, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

A replicated association between polymorphisms near TNFα and risk for adverse reactions to radiotherapy

J Chang-Claude, N G Burnet, J. Chang-Claude, 2012, British Journal of Cancer.

Individual patient data meta-analysis shows no association between the SNP rs1800469 in TGFB and late radiotherapy toxicity.

Petra Seibold, Frederik Wenz, Alison M Dunning, 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

A three-stage genome-wide association study identifies a susceptibility locus for late radiotherapy toxicity at 2q24.1

Alison M Dunning, Ángel Carracedo, Emma Hall, 2014, Nature Genetics.

Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5456 breast and prostate cancer patients.

Petra Seibold, Hubert Thierens, Alison M Dunning, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Radiogenomics: radiobiology enters the era of big data and team science.

Andre Dekker, Michael Baumann, Karin Haustermans, 2014, International journal of radiation oncology, biology, physics.

Genetic Predictors of Normal Tissue Response to Radiotherapy

A. Dunning, C. West, N. Burnet, 2010 .

Evaluation of Deep Learning to Augment Image-Guided Radiotherapy for Head and Neck and Prostate Cancers

Anton Schwaighofer, B. Glocker, O. Oktay, 2020, JAMA network open.

Radiogenomics Consortium Genome-Wide Association Study Meta-Analysis of Late Toxicity After Prostate Cancer Radiotherapy

K. Hao, H. Ostrer, G. Pandey, 2019, Journal of the National Cancer Institute.

Randomized controlled trial of intensity-modulated radiotherapy for early breast cancer: 5-year results confirm superior overall cosmesis.

C. Coles, G. Wishart, N. Twyman, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Anatomical change during radiotherapy for head and neck cancer, and its effect on delivered dose to the spinal cord

R. Jena, N. Burnet, K. Harrison, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Tumour Volume and Dose Influence Outcome after Surgery and High-dose Photon Radiotherapy for Chordoma and Chondrosarcoma of the Skull Base and Spine.

N. Burnet, S. Jefferies, G. Barnett, 2018, Clinical oncology (Royal College of Radiologists (Great Britain)).

Association of breast tumour bed seroma with post-operative complications and late normal tissue toxicity: results from the Cambridge Breast IMRT trial.

C. Coles, G. Wishart, C. Wilson, 2012, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial

I. Ellis, P. Evans, M. Sculpher, 2017, The Lancet.

Standardized Total Average Toxicity score: a scale- and grade-independent measure of late radiotherapy toxicity to facilitate pooling of data from different studies.

A. Dunning, P. Pharoah, C. Coles, 2012, International journal of radiation oncology, biology, physics.

Meta-GWAS identifies the heritability of acute radiation-induced toxicities in head and neck cancer.

R. Steenbakkers, J. Dennis, A. Crijns, 2022, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Post-Operative Radiotherapy for Soft Tissue Sarcoma of the Anterior Compartment of the Thigh: Should the Sartorius Muscle be Included?

N. Twyman, N. Burnet, S. Jefferies, 2005, Sarcoma.

Patient reported outcome measures (PROMs) following forward planned field-in field IMRT: results from the Cambridge Breast IMRT trial.

C. Coles, G. Wishart, N. Twyman, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Normal tissue reactions to radiotherapy: towards tailoring treatment dose by genotype

Alison M. Dunning, Neil G. Burnet, Charlotte E. Coles, 2009, Nature Reviews Cancer.

Risk factors for the incidence of breast cancer: do they affect survival from the disease?

D. Easton, P. Pharoah, M. Shah, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction

K. D. Sørensen, Ali Amin Al Olama, Lilit C Moss, 2021, Nature Genetics.

Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction

K. D. Sørensen, Ali Amin Al Olama, Lilit C Moss, 2021, Nature genetics.

Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants

K. D. Sørensen, Ali Amin Al Olama, H. Ostrer, 2018, Nature Communications.

A randomised controlled trial of forward-planned radiotherapy (IMRT) for early breast cancer: baseline characteristics and dosimetry results.

C. Coles, N. Twyman, N. Burnet, 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

OP-JNCI190078 1..12

Sydes, H. Ostrer, G. Pandey, 2019 .

RAPPER: the radiogenomics of radiation toxicity.

D. Dearnaley, A. Dunning, P. Pharoah, 2013, Clinical oncology (Royal College of Radiologists (Great Britain)).

A genome-wide association study of radiotherapy induced toxicity in head and neck cancer patients identifies a susceptibility locus associated with mucositis

A. Dunning, C. Luccarini, B. Alizadeh, 2022, British Journal of Cancer.

Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer

Richard Stock, Matthew R. Sydes, Kyriaki Michailidou, 2016, EBioMedicine.

Vocal fold palsy due to plombage for tuberculosis

I. Smith, J. Shneerson, G. Barnett, 2005, The Journal of Laryngology & Otology.

Incorporating Genetic Biomarkers into Predictive Models of Normal Tissue Toxicity.

A. Dunning, N. Burnet, S. Kerns, 2015, Clinical oncology (Royal College of Radiologists (Great Britain)).

Exploiting biological and physical determinants of radiotherapy toxicity to individualize treatment

J. E. Scaife, R. Jena, N. Burnet, 2015, The British journal of radiology.

BJRD15172 1..14

R. Jena, N. Burnet, J. Scaife, 2015 .

No association between SNPs regulating TGF-β1 secretion and late radiotherapy toxicity to the breast: results from the RAPPER study.

Alison M Dunning, Caroline Baynes, Neil G Burnet, 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Radiogenomics in the Era of Advanced Radiotherapy.

A. Dunning, N. Burnet, G. Barnett, 2019, Clinical oncology (Royal College of Radiologists (Great Britain)).

Information given to patients about adverse effects of radiotherapy: a survey of patients' views.

S. Charman, G. Barnett, B. Sizer, 2004, Clinical oncology (Royal College of Radiologists (Great Britain)).

Genetics and genomics of radiotherapy toxicity: towards prediction

Catharine M West, Gillian C Barnett, C. West, 2011, Genome Medicine.

Randomized controlled trial of forward-planned intensity modulated radiotherapy for early breast cancer: interim results at 2 years.

C. Coles, G. Wishart, N. Twyman, 2012, International journal of radiation oncology, biology, physics.

External Validation of a Predictive Model for Acute Skin Radiation Toxicity in the REQUITE Breast Cohort

J. Chang-Claude, A. Dunning, P. Seibold, 2020, Frontiers in Oncology.

XRCC1 Polymorphism Associated With Late Toxicity After Radiation Therapy in Breast Cancer Patients.

J. Chang-Claude, J. Debus, A. Dunning, 2015, International journal of radiation oncology, biology, physics.

STROGAR – STrengthening the Reporting Of Genetic Association studies in Radiogenomics

Joseph O Deasy, Alison M Dunning, Jenny Chang-Claude, 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Establishment of a Radiogenomics Consortium.

Andrzej Polanski, Karin Haustermans, Barry Rosenstein, 2010, International journal of radiation oncology, biology, physics.

RAPPER - A Success Story for Collaborative Translational Radiotherapy Research.

A. Dunning, N. Burnet, G. Barnett, 2019, Clinical oncology (Royal College of Radiologists (Great Britain)).

Radiogenomics: the search for genetic predictors of radiotherapy response.

Andre Dekker, Dirk De Ruysscher, Søren M Bentzen, 2014, Future oncology.

Conducting radiogenomic research--do not forget careful consideration of the clinical data.

Johannes A Langendijk, Clare Griffin, Dirk De Ruysscher, 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

The Cambridge Breast Intensity-modulated Radiotherapy Trial: patient- and treatment-related factors that influence late toxicity.

C. Coles, G. Wishart, N. Twyman, 2011, Clinical oncology (Royal College of Radiologists (Great Britain)).

Common genetic variation associated with increased susceptibility to prostate cancer does not increase risk of radiotherapy toxicity

M. Sydes, R. Eeles, D. Dearnaley, 2016, British Journal of Cancer.

The impact of clinical factors on the development of late radiation toxicity: results from the Medical Research Council RT01 trial (ISRCTN47772397).

M. Sydes, D. Dearnaley, S. Gulliford, 2011, Clinical oncology (Royal College of Radiologists (Great Britain)).

Patients with a High Polygenic Risk of Breast Cancer do not have An Increased Risk of Radiotherapy Toxicity

P. Pharoah, A. Dunning, K. Michailidou, 2015, Clinical Cancer Research.

The Cambridge Breast IMRT trial: comparison of clinician versus patient reported outcomes

C. Coles, W. Qian, G. Barnett, 2017 .

The Cambridge Breast Intensity-modulated Radiotherapy Trial: Comparison of Clinician- versus Patient-reported Outcomes.

C. Coles, W. Qian, C. Wilson, 2016, Clinical oncology (Royal College of Radiologists (Great Britain)).

Applying physical science techniques and CERN technology to an unsolved problem in radiation treatment for cancer: the multidisciplinary 'VoxTox' research programme.

Carola-Bibiane Schönlieb, Xiaohao Cai, Karl Harrison, 2017, CERN ideaSquare journal of experimental innovation.

Identifying risk factors for L’Hermitte’s sign after IMRT for head and neck cancer

R. Jena, N. Burnet, A. Bates, 2018, Radiation oncology.

Automatic contour propagation using deformable image registration to determine delivered dose to spinal cord in head-and-neck cancer radiotherapy

R. Jena, N. Burnet, K. Harrison, 2017, Physics in medicine and biology.

OC-0143: Analysis of 5434 patients shows a link between the ATM codon 1853 SNP and the risk of radiation-induced toxicity

J. Alsner, S. Gutiérrez‐Enríquez, M. Parliament, 2014 .

Author Correction: Germline variation at 8q24 and prostate cancer risk in men of European ancestry

K. D. Sørensen, Ali Amin Al Olama, H. Ostrer, 2019, Nature Communications.

Germline variation at 8q24 and prostate cancer risk in men of European ancestry

K. D. Sørensen, H. Ostrer, T. Sellers, 2018, Nature Communications.